Nanexa AB
Nanexa redefines injectables using proprietary nanoengineering drug delivery technology.
Oversigt
- 10–19
- Medarbejdere
- 5–10mio SEK
- Omsætning
- 2010
- Grundlagt
Nøglebeslutningstagere
David Westberg
CEO
Göran Ando
Chairman of the Board
Jonas Fransson
Head of Pharmaceutical Development
Mårten Rooth
CTO
+3 flere kontakter i Funnelfeedr
Beskrivelse
Nanexa is a pharmaceutical development company specializing in advanced drug delivery systems. Their core innovation is the proprietary PharmaShell® technology, which utilizes Atomic Layer Deposition (ALD) precision. This technology is designed to transform drug administration by enabling long-actin...